Amlodipine in mild and moderate hypertension: initial Indian experience.
dc.contributor.author | Khokhani, R C | en_US |
dc.contributor.author | Chopra, P | en_US |
dc.contributor.author | Karnik, N D | en_US |
dc.contributor.author | Bajan, K D | en_US |
dc.contributor.author | Ailiani, R | en_US |
dc.contributor.author | Waknis, S S | en_US |
dc.contributor.author | Joseph, T A | en_US |
dc.contributor.author | Chawla, K P | en_US |
dc.date.accessioned | 1993-10-01 | en_US |
dc.date.accessioned | 2009-05-30T23:31:33Z | |
dc.date.available | 1993-10-01 | en_US |
dc.date.available | 2009-05-30T23:31:33Z | |
dc.date.issued | 1993-10-01 | en_US |
dc.description.abstract | In an open, non-comparative, variable-dose study, 20 outpatients with mild to moderate essential hypertension were treated with 5-10 mg amlodipine once daily for 4 weeks, after their blood pressures had stabilized on placebo. Amlodipine produced a significant decrease in blood pressure (P < 0.05) from the initial mean of 162/100 mm Hg to 139/85 mm Hg at 4 weeks. 80% of the patients reached the goal diastolic blood pressure of < or = 90 mm Hg with a once-daily dose of 5 mg amlodipine within 2 weeks. The remaining 20% also attained the goal diastolic blood pressure within 4 weeks, with a one-step increase in the dose to 10 mg at 2 weeks. Amlodipine maintained blood pressure reduction throughout the 24-hours dosing interval with a once-daily dose. Notably, no side effects were observed; pulse rate, electrocardiogram, and laboratory parameters were not significantly altered with therapy. Amlodipine in a single daily dose of 5-10 mg is effective and well tolerated in the treatment of patients with mild to moderate hypertension. | en_US |
dc.description.affiliation | Medical Research Division, Pfizer Ltd., Bombay. | en_US |
dc.identifier.citation | Khokhani RC, Chopra P, Karnik ND, Bajan KD, Ailiani R, Waknis SS, Joseph TA, Chawla KP. Amlodipine in mild and moderate hypertension: initial Indian experience. Journal of the Association of Physicians of India. 1993 Oct; 41(10): 662-3 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/90502 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Amlodipine --therapeutic use | en_US |
dc.subject.mesh | Blood Pressure --drug effects | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypertension --drug therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Single-Blind Method | en_US |
dc.title | Amlodipine in mild and moderate hypertension: initial Indian experience. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1